EPALINGES, Switzerland, Oct. 27, 2025 /PRNewswire/ — Onward Therapeutics SA, a clinical stage oncology company, today announced that its French subsidiary, Onward Therapeutics France, has exercised its exclusive option and entered into a worldwide license agreement with Institut du…
